Tags

Type your tag names separated by a space and hit enter

Off-pump vs. on-pump coronary artery bypass surgery: an updated meta-analysis and meta-regression of randomized trials.
Eur Heart J. 2012 May; 33(10):1257-67.EH

Abstract

AIMS

The benefits of off-pump coronary artery bypass (OPCAB) continue to be debated, in part due to the fact that pooled effects fail to consider differences in trial and patient characteristics. We sought to analyse the contemporary evidence for OPCAB vs. conventional coronary artery bypass (CCAB), incorporating recent larger trials, and adjusting for differences in trials using a technique known as meta-regression.

METHODS AND RESULTS

We systematically reviewed MEDLINE, EMBASE, and the Cochrane database for published and unpublished randomized trials of OPCAB vs. CCAB in which 30-day or in-hospital clinical outcomes were reported. The outcomes of interest were: all-cause mortality, stroke, and myocardial infarction. In addition to measuring the pooled treatment effects using a random effects meta-analysis model, we measured the effect of selected trial-level factors on the effects observed using the meta-regression technique. Fifty-nine trials were included, encompassing 8961 patients with a mean age of 63.4 and 16% females. There was a significant 30% reduction in the occurrence of post-operative stroke with OPCAB [risk ratio (RR) 0.70, 95% CI: 0.49-0.99]. There was no significant difference in mortality (RR: 0.90, 95% CI: 0.63-1.30) or myocardial infarction (pooled RR: 0.89, 95% CI: 0.69-1.13). In the meta-regression analysis, the effect of OPCAB on all of the clinical outcomes was similar regardless of mean age, proportion of females in the trial, number of grafts per patient, and trial publication date.

CONCLUSION

Our meta-analysis incorporating recent trials suggests that there appears to be a beneficial effect of OPCAB on stroke. Moreover, our meta-regression does not support the hypothesis that differences in study populations are responsible for the observed outcomes, although pooled individual patient-data would be better suited to confirm these findings.

Authors+Show Affiliations

Division of Cardiology, Department of Medicine, SMBD-Jewish General Hospital, McGill University, 3755 Cote Ste Catherine, Montreal, Quebec, Canada. jonathan@afilalo.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

21987177

Citation

Afilalo, Jonathan, et al. "Off-pump Vs. On-pump Coronary Artery Bypass Surgery: an Updated Meta-analysis and Meta-regression of Randomized Trials." European Heart Journal, vol. 33, no. 10, 2012, pp. 1257-67.
Afilalo J, Rasti M, Ohayon SM, et al. Off-pump vs. on-pump coronary artery bypass surgery: an updated meta-analysis and meta-regression of randomized trials. Eur Heart J. 2012;33(10):1257-67.
Afilalo, J., Rasti, M., Ohayon, S. M., Shimony, A., & Eisenberg, M. J. (2012). Off-pump vs. on-pump coronary artery bypass surgery: an updated meta-analysis and meta-regression of randomized trials. European Heart Journal, 33(10), 1257-67. https://doi.org/10.1093/eurheartj/ehr307
Afilalo J, et al. Off-pump Vs. On-pump Coronary Artery Bypass Surgery: an Updated Meta-analysis and Meta-regression of Randomized Trials. Eur Heart J. 2012;33(10):1257-67. PubMed PMID: 21987177.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Off-pump vs. on-pump coronary artery bypass surgery: an updated meta-analysis and meta-regression of randomized trials. AU - Afilalo,Jonathan, AU - Rasti,Mandana, AU - Ohayon,Samuel M, AU - Shimony,Avi, AU - Eisenberg,Mark J, Y1 - 2011/10/10/ PY - 2011/10/12/entrez PY - 2011/10/12/pubmed PY - 2012/7/31/medline SP - 1257 EP - 67 JF - European heart journal JO - Eur Heart J VL - 33 IS - 10 N2 - AIMS: The benefits of off-pump coronary artery bypass (OPCAB) continue to be debated, in part due to the fact that pooled effects fail to consider differences in trial and patient characteristics. We sought to analyse the contemporary evidence for OPCAB vs. conventional coronary artery bypass (CCAB), incorporating recent larger trials, and adjusting for differences in trials using a technique known as meta-regression. METHODS AND RESULTS: We systematically reviewed MEDLINE, EMBASE, and the Cochrane database for published and unpublished randomized trials of OPCAB vs. CCAB in which 30-day or in-hospital clinical outcomes were reported. The outcomes of interest were: all-cause mortality, stroke, and myocardial infarction. In addition to measuring the pooled treatment effects using a random effects meta-analysis model, we measured the effect of selected trial-level factors on the effects observed using the meta-regression technique. Fifty-nine trials were included, encompassing 8961 patients with a mean age of 63.4 and 16% females. There was a significant 30% reduction in the occurrence of post-operative stroke with OPCAB [risk ratio (RR) 0.70, 95% CI: 0.49-0.99]. There was no significant difference in mortality (RR: 0.90, 95% CI: 0.63-1.30) or myocardial infarction (pooled RR: 0.89, 95% CI: 0.69-1.13). In the meta-regression analysis, the effect of OPCAB on all of the clinical outcomes was similar regardless of mean age, proportion of females in the trial, number of grafts per patient, and trial publication date. CONCLUSION: Our meta-analysis incorporating recent trials suggests that there appears to be a beneficial effect of OPCAB on stroke. Moreover, our meta-regression does not support the hypothesis that differences in study populations are responsible for the observed outcomes, although pooled individual patient-data would be better suited to confirm these findings. SN - 1522-9645 UR - https://www.unboundmedicine.com/medline/citation/21987177/Off_pump_vs__on_pump_coronary_artery_bypass_surgery:_an_updated_meta_analysis_and_meta_regression_of_randomized_trials_ L2 - https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehr307 DB - PRIME DP - Unbound Medicine ER -